The expression of the Chromodomain-helicase DNA binding protein 5 (CHD5) gene was recently shown to be elevated after 7 days of CRA treatment in SH-SY5Y, NGP, and SK-N-DZ neuroblastoma cells (33), although the increased expression was seen after the induction of morphologic neuroblastoma differentiation. Here, CHD5 is linked to neuroblastoma.